The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy

Haematologica

Volumn 92, Issue 9, 2007, Pages 1230-1237

  Pereg, David ^a,b   Koren, Gideon ^c   Lishner, Michael ^a,b,c  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Chemotherapy; Fetus; Lymphoma; Malformations; Pregnancy

Indexed keywords

AMINOGLYCOSIDE; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BLEOMYCIN; CEPHALOSPORIN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ERYTHROMYCIN; ERYTHROPOIETIN; ETOPOSIDE; FLUDARABINE; FOLIC ACID ANTAGONIST; GRANULOCYTE COLONY STIMULATING FACTOR; METOCLOPRAMIDE; ONDANSETRON; PENICILLIN G; PREDNISONE; PROCARBAZINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RITUXIMAB; SULFONAMIDE; TETRACYCLINE; UNINDEXED DRUG; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ARTHROPATHY; ARTICLE; BONE DISEASE; BREAST CANCER; BREAST FEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER THERAPY; CARDIOMYOPATHY; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CYTOPENIA; DRUG INDUCED DISEASE; EMBRYO DEVELOPMENT; FETAL B CELL DEPLETION; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GROWTH RETARDATION; HODGKIN DISEASE; HUMAN; HYDROCEPHALUS; LYMPHOMA; NEURAL TUBE DEFECT; NONHODGKIN LYMPHOMA; NONHUMAN; PREGNANCY; PREGNANCY TERMINATION; RISK; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; STILLBIRTH; TOOTH DISEASE;

FEMALE; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 36348963664     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11097     Document Type: Article

References (67)

1. Pentheroudakis G, Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 2006;42:126-40.
2. Koren G, Lishner M, Santiago S. The Motherisk Guide to Cancer in Pregnancy and Lactation (Second edition). Toronto, Canada. Motherisk program; 2005.
3. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist 2002;7:279-87.
4. Diamond C, Taylor TH, Aboumrad T, Anton-Culver H. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer 2006;106:128-35.
5. Cheung MC, Pantanowitz L, Dezube BJ. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist 2005;10:412-26.
6. Weisz B, Meirow D, Schiff E, Lishner M. Impact and treatment of cancer during pregnancy. Exper Rev Anticancer Ther 2004;4:889-902.
7. Cohen-Kerem R, Railton C, Oren D, Lishner M, Koren G. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg 2005;190:467-73.
8. Lishner M, Zemlickis D, Sutcliffe SB, Koren G. Non-Hodgkin's lymphoma and pregnancy. Leuk Lymphoma 1994;14:411-3.
9. Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 2005;6:328-33.
10. Cohen-Kerem R, Nulman I, Abramow-Newerly M, Medina D, Maze1 R, Brent RL, et al. Diagnostic radiation in pregnancy: perception versus true risks. J Obstet Gynaecol Can 2006;28: 43-48.
11. Kawabata I, Takahashi Y, Iwagaki S, Tamaya T. MRI during pregnancy. J Perinat Med 2003;31:449-58.
12. Levine D. Obstetric MRI. J Magn Reson Imaging 2006;24:1-15.
13. Hicks RJ, Binns D, Stabin MG. Pattern of uptake and excretion of (18)F-FDG in the lactating breast. J Nucl Med 2001;42:1238-42.
14. Benveniste H, Fowler JS, Rooney WD, Moller DH, Backus WW, Warner DA, et al. Maternal-fetal in vivo imaging: a combined PET and MRI study. J Nucl Med 2003;44:1522-30.
15. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283-91.
16. Leslie KK, Koil C, Rayburn WF. Chemotherapeutic drugs in pregnancy. Obstet Gynecol Clin North Am 2005; 32:627-40.
17. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992;152:573-6.
18. Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch Intern Med 1998; 148: 2058-64.
19. Randall T. National registry seeks scarce data on pregnancy outcomes during chemotherapy. JAMA 1993; 269: 323.
20. Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol 2006;49:257-69.
21. Kistner A, Celsi G, Vanpee M, Jacobson SH. Increased blood pressure but normal renal function in adult women born preterm. Pediatr Nephrol 2000;15:215-20.
22. Yudkin JS, Martyn CN, Phillips DI, Gale CR. Associations of micro-albuminuria with intra-uterine growth retardation. Nephron 2001;89:309-14.
23. Aviles A, Neri N, Nambo MJ. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 2006; 17:286-8.
24. Siu BL, Alonzo MR, Vargo TA, Fenrich AL. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer 2002; 12: 399-402.
25. Achtari C, Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Gynecol 2000;183:511-2.
26. Fenig E, Mishaeli M, Kalish Y, Lishner M. Pregnancy and radiation. Cancer Treat Rev 2001;27:1-7.
27. International Commission of Radiological Protection. Biological effects after prenatal irradiation. Ann ICRP 2003;33:205-6.
28. Otake M, Schull WJ. Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivors. Int J Radiat Biol 1998; 74:159-71.
29. Asker C, Wikner B, Kallen B. Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol 2005; 61: 899-906.
30. Einarson A, Maltepe C, Navioz Y, Kennedy D, Tan MP, Koren G. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 2004; 111: 940-3.
31. Lynch CM, Sinnott JT 4th, Holt DA, Herold AH. Use of antibiotics during pregnancy. Am Fam Physician 1991; 43:1365-8.
32. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 2001;15:637-46.
33. Sifakis S, Angelakis E, Vardaki E, Koumantaki Y, Matalliotakis I, Koumantakis E. Erythropoietin in the treatment of iron deficiency anemia during pregnancy. Gynecol Obstet Invest 2001;51:150-6.
34. Aviles A, Diaz-Maqueo JC, Talavera A, Guzman R Garcia EL. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol 1991;36:243-8.
35. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001;2:173-7.
36. Weisz B, Schiff E, Lishner M. Cancer in pregnancy: maternal and fetal implications. Hum Reprod Update 2001; 7: 384-93.
37. Lishner M, Zemlickis D, Degendorfer P, Panzarella T Sutcliffe SB, Koren G. Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br J Cancer 1992;65:114-7.
38. Zuazu J, Julia A, Sierra J, Valentin MG, Coma A, Sanz MA, et al. Pregnancy outcome in hematologic malignancies. Cancer 1991;67:703-9.
39. Peres RM, Sanseverino MT, Guimaraes JL, Coser V, Giuliani L, Moreira RK, et al. Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res 2001;34:1551-9.
40. Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Management of the pregnant patient with Hodgkin's disease. Ann Intern Med 1981;95:669-75.
41. Diav-Citrin O, Arnon J, Shechtman S, Schaefer C, van Tonningen MR, Clementi M, et al. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 2005; 21:269-75.
42. Lishner M, Zemlickis D, Sutcliffe SB, Koren G. Non-Hodgkin's lymphoma and pregnancy. Leuk Lymphoma 1994;14:411-3.
43. Guven S, Ozcebe OI, Tuncer ZS. Non-Hodgkin's lymphoma complicating pregnancy: a case report. Eur J Gynaecol Oncol 2005;26:457-8.
44. Mavrommatis CG, Daskalakis GJ, Papageorgiou IS, Antsaklis AJ, Michalas SK. Non-Hodgkin's lymphoma during pregnancy: case report. Eur J Obstet Gynecol Reprod Biol 1998; 79: 95-7.
45. Kirkpatrick AW, Bailey DJ, Weizel HA. Bilateral primary breast lymphoma in pregnancy: a case report and literature review. Can J Surg 1996;39:333-5.
46. Lambert J, Wijermans PW, Dekker GA, Ossenkoppele GJ. Chemotherapy in non-Hodgkin's lymphoma during pregnancy. Neth J Med 1991;38:80-5.
47. Ba-Thike K, Oo N. Non-Hodgkin's lymphoma in pregnancy. Asia Oceania J Obstet Gynaecol 1990;16:229-32.
48. Garg A, Kochupillai V. Non-Hodgkin's lymphoma in pregnancy. South Med J 1985;78:1263-4.
49. Morice P, Cristalli B, Heid M, Briere J, Levardon M. Pregnancy and non-Hodgkin's lymphoma: a case report. J Gynecol Obstet Biol Reprod (Paris). 1993;22:68-70.
50. Garcia L, Valcarcel M, Santiago-Borrero PJ. Chemotherapy during pregnancy and its effects on the fetus-neonatal myelosuppression: two case reports. J Perinatol 1999;19:230-3.
51. Moore DT, Taslimi MM. Non-Hodgkin's lymphoma in pregnancy: a diagnostic dilemma. Case report and review of the literature. J Tenn Med Assoc 1992;85:467-9.
52. Falkson HC, Simson IW, Falkson G. Non-Hodgkin's lymphoma in pregnancy. Cancer 1980;45:1679-82.
53. Ortega J. Multiple agent chemotherapy including bleomycin of non-Hodgkin's lymphoma during pregnancy. Cancer 1977;40:2829-35.
54. Herold M, Schnohr S, Bittrich H. Efficacy and safety of a combined rituximab chemotherapy during pregnancy. J Clin Oncol. 2001;19:3439.
55. Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999;17:855-61.
56. Ojeda-Uribe M, Gilliot C, Jung G, Drenou B, Brunot A. Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J Perinatol 2006;26:252-5.
57. Kimby E, Sverrisdottir A, Elinder G. Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol 2004;72:292-5.
58. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum. 2005;35:112-21.
59. Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N. The effects of rituximab treatment during pregnancy on a neonate. Haematologica 2006;91:1426-7.
60. Meguerian-Bedoyan Z, Lamant L, Hopfner C, Pulford K, Chittal S, Delsol G. Anaplastic large cell lymphoma of maternal origin involving the placenta: case report and literature survey. Am J Surg Pathol 1997;21:1236-41.
61. Nuiman I, Laslo D, Fried S, Uleryk E, Lishner M, Koren G. Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br J Cancer 2001;85:1611-18.
62. Matalon ST, Ornoy A, Lishner M. The effect of 6-mercaptopurine on early human placental explants. Hum Reprod 2005;20:1390-7.
63. DeLoia JA, Stewart-Akers AM, Creinin MD. Effects of methotrexate on trophoblast proliferation and local immune responses. Hum Reprod 1998; 13:1063-9.
64. Matalon ST, Ornoy A, Lishner M. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin) on the embryo and placenta. Reprod Toxicol 2004;18:219-30.
65. Kraemer J, Klein J, Lubetsky A, Koren G. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol 2006;195:270-4.
66. Hnat M, Bawdon RE. Transfer of meropenem in the ex vivo human placenta perfusion model. Infect Dis Obstet Gynecol 2005;13:223-7.
67. Polachek H, Holeberg G, Sapir G, Tsadkin-Tamir M, Polachek J, Katz M, et al. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 2005; 122:61-5.